TCL Archive NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening November 5, 2010
TCL Archive Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says June 19, 1998
TCL Archive FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity? August 15, 1997
TCL Archive Ohio Judge Fines CareToLive Prostate Cancer Group That Sought The Cancer Letter’s Confidential Source Material On Provenge. February 29, 2008
